In this podcast we take a look at the FDA’s new guidance to facilitate changes to container-closure-system components due to supply constraints, plus updates from suppliers of materials used to deliver COVID-19 vaccines, treatments and other parenteral drugs. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers)
2020 in Review: The Top 10 Developments
- FDA addresses supply constraints
- Suppliers increase production
Sponsor: Vetter Pharma International GmbH